(Palivizumab)Biosimilar Reference Antibody(Respiratory Syncytial Virus Glycoprotein F)
(Palivizumab)Biosimilar Reference Antibody(Respiratory Syncytial Virus Glycoprotein F)
(Palivizumab)Biosimilar Reference Antibody(Respiratory Syncytial Virus Glycoprotein F)

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

(Palivizumab)Biosimilar Reference Antibody(Respiratory Syncytial Virus Glycoprotein F)
Cat:
GS40527
Type:
Antibody
Immunogen:
Respiratory Syncytial Virus Glycoprotein F
ELISA plate pre-coated Antigen protein, can bind Palivizumab biosimilar in a linear range of 0.18–15 ng/mL.
Reactivity:
Human
Applications:
ELISA,IF; Recommended dilution: WB:1:5000, IF:1:50-1:200, FC:1:100-1:300
Price:
(Palivizumab)Biosimilar Reference Antibody(GS40527) on SDS-PAGE under non-reducing (NR) and reducing (R) condition.
  • Product details
Product Name
(Palivizumab)Biosimilar Reference Antibody(Respiratory Syncytial Virus Glycoprotein F)
Cat
GS40527
Heavy chain
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS
Light chain
DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK
Isotype
IgG1 - kappa
Host
Humanised
Purity
>95% by SDS-PAGE
Endotoxin
<1.0 EU/μg as determined by LAL method
Immunogen
Respiratory Syncytial Virus Glycoprotein F
Reactivity
Human
Applications
ELISA,IF; Recommended dilution: WB:1:5000, IF:1:50-1:200, FC:1:100-1:300
Conjugated
Non-conjugated
Buffer
Preservative:0.01M PBS, PH 7.4
Storage
store at -20°C or -80°C. Avoid repeated freeze.
Type
Antibody
Purposes
For research use only